Figure 1

The comparison of oxidant-antioxidant biomarkers and ADMA levels. Data are presented as mean ± standard deviation in Figure A, C and D, presented as median (interquartile range) in Figure B. A. There was no significant difference in the level of d-ROMs between PAH group and PAH-control group, or between CTEPH and CTEPH-control group. B. The level of MDA was higher in PAH and CTEPH patients than that in their control group. The difference was only significant between CTEPH group and CTEPH-control group. C. Compared with controls, the level of BAP was significantly lower in patients with PAH or CTEPH. D. Compared with controls, the level of SOD was significantly lower in patients with PAH or CTEPH. E. Compared with controls, the level of ADMA was significantly higher in patients with PAH or CTEPH.